Infertility

Global L-Carnitine Market Report 2021: Size, Share & Trends Analysis by Process (Bioprocess, Chemical Synthesis), Product (Food & Pharmaceutical Grade, Feed Grade) - ResearchAndMarkets.com

Friday, October 15, 2021 - 2:47pm

The "L-Carnitine Market Size, Share & Trends Analysis Report by Process (Bioprocess, Chemical Synthesis), by Product (Food & Pharmaceutical Grade, Feed Grade), by Application, by Region, and Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "L-Carnitine Market Size, Share & Trends Analysis Report by Process (Bioprocess, Chemical Synthesis), by Product (Food & Pharmaceutical Grade, Feed Grade), by Application, by Region, and Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.
  • The global L-carnitine market size is expected to reach USD 276.0 million by 2028, expanding at a CAGR of 5.1%.
  • Growing consumer awareness regarding product benefits, along with increasing demand from end-use industries such as pharmaceutical, nutraceutical, and animal feed, is projected to drive the market over the forecast period.
  • L-carnitine and its derivatives are used for numerous applications including male infertility, kidney treatment, cardiovascular diseases, weight reduction, and bone mass.

United States Infertility Treatment Devices Market Report 2021-2027: Focus on Sperm Separation Devices, Ovum Aspiration Pumps, Sperm Analyzer Systems, Micromanipulator Systems, Microscopes, Incubators - ResearchAndMarkets.com

Friday, October 15, 2021 - 12:51pm

The "United States Infertility Treatment Devices Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Infertility Treatment Devices Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The country research report on the United States infertility treatment devices market is a customer intelligence and competitive study of the United States market.
  • The companies and dealers/distributors profiled in the report include manufacturers & suppliers of infertility treatment devices market in the United States.
  • 5) What are the modes of entering the United States infertility treatment devices market?

Organon Launches New Fertility Journey Website as Part of Ongoing Commitment to Help Address the Needs of Women

Friday, October 15, 2021 - 11:50am

The website aims to meet people wherever they are on their fertility journey and equip them with knowledge and questions for consideration to feel prepared and empowered throughout their journey.

Key Points: 
  • The website aims to meet people wherever they are on their fertility journey and equip them with knowledge and questions for consideration to feel prepared and empowered throughout their journey.
  • We want to provide support to anyone looking to start a family and for those accompanying them.
  • I am proud to work at Organon where we are truly devoted to understanding the journey.
  • Every fertility journey is a personal one, but many on this road have similar questions.

AAGL to Offer an Extensive Lineup of Postgraduate and Continuing Medical Education Courses for the 50th Annual Global Congress on Minimally Invasive Gynecologic Surgery

Friday, October 15, 2021 - 11:00am

The Scientific Program at AAGL annual meetings are always meticulously developed and are renowned for offering the best in MIGS education.

Key Points: 
  • The Scientific Program at AAGL annual meetings are always meticulously developed and are renowned for offering the best in MIGS education.
  • This year's curriculum will consist of PG Courses, Hands-on Surgical Labs, Plenary Sessions, Panels, Debates and Open Communication breakout sessions.
  • Premiering this year, AAGL is excited to introduce AAGL Talks, 15-minute TED-like presentations prior to the General Sessions, that will also provide CME credits.
  • AAGL is a professional medical association of laparoscopic surgeons and is the global leader in minimally invasive gynecologic surgery.

International Federation of Fertility Societies Supports Individuals Globally with Fertility Plans During the Pandemic

Thursday, October 14, 2021 - 7:00pm

MOUNT ROYAL, N.J., Oct. 14, 2021 /PRNewswire-PRWeb/ -- The International Federation of Fertility Societies (IFFS) created a global infographic campaign aimed at providing support to individuals around the world who are looking to safely start or resume their fertility plans during the COVID-19 Pandemic.

Key Points: 
  • MOUNT ROYAL, N.J., Oct. 14, 2021 /PRNewswire-PRWeb/ -- The International Federation of Fertility Societies (IFFS) created a global infographic campaign aimed at providing support to individuals around the world who are looking to safely start or resume their fertility plans during the COVID-19 Pandemic.
  • IFFS saw the need for information that reaches a global audience, thus creating the infographics offered in a variety of languages.
  • The Federation will be monitoring and utilizing the hashtag #THINKINGOFHAVINGABABY and encourage like-minded organizations to do the same when sharing the materials.
  • IFFS represents over 65 UN country specific fertility societies that in the aggregate, encompass an estimated 50,000 physicians and reproduction medicine specialists worldwide including various healthcare professionals.

INVO Bioscience Announces Grand Opening of "Positib Fertility, an INVO Center" in Monterrey, Mexico on November 1, 2021

Thursday, October 14, 2021 - 2:00pm

This becomes the first INVO Center in Mexico and follows the recent openings of INVO Centers in Birmingham, Alabama and Atlanta, Georgia.

Key Points: 
  • This becomes the first INVO Center in Mexico and follows the recent openings of INVO Centers in Birmingham, Alabama and Atlanta, Georgia.
  • Positib Fertility, an INVO Center, is a partnership between INVO Bioscience and experienced reproductive specialist Dr. Francisco Arredondo, MD., MPH and Dr. Ramiro Ramirez Gutierrez, MD.
  • Dr. Arredondo successfully sold his U.S.-based fertility clinics in 2019 and is now focused on bringing the INVOcell solution to Mexico.
  • Steve Shum, CEO of INVO Bioscience, commented, "This is yet another milestone in the history of the Company and the INVOcell solution as we announce the grand opening of our first INVO Center in Mexico.

Advancements in reproductive medicine available at Shady Grove Fertility (SGF) can reduce the inheritance of genetic diseases like breast cancer

Thursday, October 14, 2021 - 1:45pm

Individuals and couples with known genetic diseases can turn to Shady Grove Fertility (SGF) to undergo in vitro fertilization (IVF) with preimplantation genetic testing for monogenic/single gene defects(PGT-M) to reduce the risk of passing genetic mutations to future offspring.

Key Points: 
  • Individuals and couples with known genetic diseases can turn to Shady Grove Fertility (SGF) to undergo in vitro fertilization (IVF) with preimplantation genetic testing for monogenic/single gene defects(PGT-M) to reduce the risk of passing genetic mutations to future offspring.
  • Additionally, patients at risk for dominant gene mutations, such as breast cancer or inherited forms of colon cancer, can have individualized testing for these diseases.
  • While Rose is not a carrier for the breast cancer gene, she is a carrier of a rare X-linked genetic mutation called Wiskott-Aldrich syndrome.
  • We are so fortunate to live in a world where we can now reduce the inheritance of deadly genetic diseases via IVF.

CCRM Fertility Colorado and TMRW Life Sciences Partner in State-of-the-Art Technology for the Safe Management of Eggs and Embryos for IVF Patients

Thursday, October 14, 2021 - 1:00pm

"In partnership with TMRW, we're implementing new capabilities for the safe management of eggs and embryos, including software-guided specimen management, 24/7 remote monitoring, unique digital identification for each sample and touch-of-a-button inventory management within the lab."

Key Points: 
  • "In partnership with TMRW, we're implementing new capabilities for the safe management of eggs and embryos, including software-guided specimen management, 24/7 remote monitoring, unique digital identification for each sample and touch-of-a-button inventory management within the lab."
  • TMRW Life Sciences has created the first automated solution for how frozen eggs and embryos are stored, tracked, and monitored during the IVF process.
  • The TMRW platform is transforming the possibilities for fertility and family planning by safeguarding the most precious cells for life.
  • Founded by Dr. William Schoolcraft in 1987, CCRM (Colorado Center for Reproductive Medicine)Fertilityis the nation's leader in fertility care and research.

Cicero Diagnostics reaches 10,000-patient milestone with its ReceptivaDx™ Test

Thursday, October 14, 2021 - 11:00am

Womens healthcare company, Cicero Diagnostics Inc., offering ReceptivaDx for unexplained infertility, implantation failure and recurrent pregnancy loss, today announced it has reached the 10,000-patient mark from fertility centers using ReceptivaDx and its signature BCL6 marker.

Key Points: 
  • Womens healthcare company, Cicero Diagnostics Inc., offering ReceptivaDx for unexplained infertility, implantation failure and recurrent pregnancy loss, today announced it has reached the 10,000-patient mark from fertility centers using ReceptivaDx and its signature BCL6 marker.
  • The milestone signifies substantial test growth since the companys inception and reflects the role ReceptivaDx now plays as a new standard of care in fertility centers helping patients who have experienced IVF failure.
  • Today ReceptivaDx is used by more than 350 fertility centers around the country and has been introduced in several strategic international markets with more expected, said Chris Jackson, CEO Cicero Diagnostics.
  • Cicero Diagnostics is the exclusive licensed provider of the BCL6 test for the detection of uterine lining dysfunction commonly associated with endometriosis.

SGF Jones Institute physician, Tarita Pakrashi, M.D., M.P.H., named to Coastal Virginia Magazine's 2021 Top Doctors list

Wednesday, October 13, 2021 - 10:30pm

NORFOLK, Va., Oct. 13, 2021 /PRNewswire-PRWeb/ -- Shady Grove Fertility (SGF) is proud to announce that Tarita Pakrashi, M.D., M.P.H ., who sees patients at SGF Jones Institute in Norfolk , has been named to Coastal Virginia Magazine's 2021 Top Doctors list.

Key Points: 
  • NORFOLK, Va., Oct. 13, 2021 /PRNewswire-PRWeb/ -- Shady Grove Fertility (SGF) is proud to announce that Tarita Pakrashi, M.D., M.P.H ., who sees patients at SGF Jones Institute in Norfolk , has been named to Coastal Virginia Magazine's 2021 Top Doctors list.
  • Coastal Virginia Magazine conducts an annual peer-to-peer survey by Data Joe, an independent firm with no ties to the magazine or the medical community.
  • The 2021 Top Docs list is compiled of 668 physicians across 80 specialties.
  • SGF Jones Institute provides a full range of diagnostic and treatment options to help individuals and couples achieve their family-building goals, including: